[Pathophysiology of immunological processes. 3. Therapeutic influencing].
D000368:Aged; D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy; D000917:Antibody Formation / Q000187:drug effects*; D000937:Antigen-Antibody Reactions / Q000187:drug effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001327:Autoimmune Diseases / Q000188:drug therapy*; D001379:Azathioprine / Q000627:therapeutic use; D001663:Bilirubin / Q000097:blood; D004247:DNA / Q000096:biosynthesis; D006505:Hepatitis / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000188:drug therapy; D014176:Protein Biosynthesis; D012313:RNA / Q000096:biosynthesis; D012270:Ribosomes / Q000378:metabolism; D013921:Thrombocytopenia / Q000188:drug therapy; D000637:Transaminases / Q000097:blood
D007166:Immunosuppressive Agents; D012313:RNA; D004247:DNA; D000637:Transaminases; D001379:Azathioprine; D001663:Bilirubin
Die Pathophysiologie der Immunitätsvorgänge. 3. Therapeutische Beeinflussung.